GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed Aug 20, 2012 · 10-Q · 51 days after period end · 0001513160-12-000059
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $1.00K | $1.00K | $0.00 |
| Net Income | -$2.40M | -$662.00K | $399.00K |
| EPS Diluted | -$0.01 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 20, 2012 · 51 d after period end
